The mutation in the ␣ 1A
channels are also up-regulated at neuromuscular junctions of tg mice is unknown. We characterized thoroughly the pharmacological sensitivity of the Ca 2ϩ channels, which control ACh release at adult tg neuromuscular junctions. Block of N-and R-type (Ca v 2.2-2.3), but not L-type Ca 2ϩ channels, significantly reduced quantal content of end-plate potentials in tg preparations. Neither resting nor KCl-evoked miniature end-plate potential frequency differed significantly between tg and wild type (WT). Immunolabeling of Ca 2ϩ channel subunits ␣ 1A , ␣ 1B , ␣ 1C , and ␣ 1E revealed an apparent increase of ␣ 1B , and ␣ 1E staining, at tg but not WT neuromuscular junctions. This presumably compensates for the deficit of P/Q-type Ca 2ϩ channels, which localized presynaptically at WT neuromuscular junctions. No ␣ 1C subunits juxtaposed with pre-or postsynaptic markers at either WT or tg neuromuscular junctions. Thus, in adult tg mice, immunocytochemical and electrophysiological data indicate that N-and R-type channels both assume control of ACh release at motor nerve terminals. Recruitment of alternate subtypes of Ca 2ϩ channels to control transmitter release seems to represent a commonly occurring method of neuronal plasticity. However, it is unclear which conditions underlie recruitment of Ca v 2 as opposed to Ca v 1-type Ca 2ϩ channels.
Influx of Ca 2ϩ through high-voltage-activated Ca 2ϩ channels triggers neurotransmitter release (Augustine and Charlton, 1986) . Different Ca 2ϩ channels are distinguished based on the genes that encode them and their pharmacological and biophysical characteristics.
Most of the subtype-specific attributes of Ca 2ϩ channels are due to the ␣ 1 subunit, which makes up the selective pore for Ca 2ϩ , contains binding sites for various pharmacological agents, and possesses the gating regions of the channel (Zhang et al., 1993) . At least five ␣ 1 subunits for neuronal Ca 2ϩ channels are known. The ␣ 1A , ␣ 1B , and ␣ 1E subunits represent the P/Q-type (Ca v 2.1), N-type (Ca v 2.2), and R-type (Ca v 2.3) Ca 2ϩ channels, respectively. The ␣ 1C or ␣ 1D represents L-type channels (Ca v 1.2-1.3) (Tsien et al., 1991) . The anatomical location, time in development, and age of the animal all affect the expression of specific Ca 2ϩ channel subtypes; multiple phenotypes coexist in the same cell. This redundancy modulates critical functions by allowing the various channel subtypes to act in concert; however, distinct channel subtypes may also be differentially localized and spatially separated in the same cell.
Other factors also affect the expression and localization of Ca 2ϩ channel subtypes. In mammals, ACh release from adult somatic motor nerve terminals is mediated predominantly by P/Q-type Ca 2ϩ channels (Uchitel et al., 1992) , whereas in amphibians and birds, it is mediated by N-type Ca 2ϩ channels (Robitaille et al., 1990; De Luca et al., 1991) . P-and Q-type Ca 2ϩ channels, originally described in cerebellar Purkinje and granule cells, respectively (Lliná s et al., 1989; Randall and Tsien, 1995) , are widely distributed and mediate neurotransmitter release at central and peripheral synapses. L-type Ca 2ϩ channels can also contribute to secretory function. These participate in ACh release at neuromuscular junction in certain situations (Suguira and Ko, 1997; Urbano et al., 2003) . R-and N-type Ca 2ϩ channels also substitute for P/Q-channels in controlling ACh release (Urbano et al., 2003) at neuromuscular junction. The conditions that determine what subtypes of Ca 2ϩ channel participate in secretory function are, as yet unclear, but they have important implications for synaptic plasticity.
Several natural mutations of P/Q-type Ca 2ϩ channels such as tottering (tg) have been identified in mice. They have been used to study inherited neurological disorders (Burgess and Noebels, 1999; Pietrobon, 2002) . The tg mutation encodes a proline-to-leucine amino acid substitution in the S5-S4 linker region of repeat domain II of the ␣ 1A subunit (Fletcher et al., 1996) . This reduces whole-cell current density and voltagedependent inactivation during prolonged depolarization of Purkinje cells, without affecting single Ca 2ϩ channel conductance (Wakamori et al., 1998) . As a result, P/Q-type Ca 2ϩ channel function is compromised, and neurotransmitter release at hippocampal and cerebellar synapses now depends predominantly on N-type channels (Qian and Noebels, 2000; Zhou et al., 2003) . Stereotypic behavior is induced by the L-type agonist BayK 8644 in tg but not wild-type (WT) animals (Campbell and Hess, 1999) . L-type channel ␣ 1C subunit mRNA was also up-regulated in Purkinje cells (Campbell and Hess, 1999) and basal forebrain neurons (Etheredge et al., 2005) of tg mice, suggesting that the L-type phenotype is newly expressed, or unmasked. In hippocampal slices taken from animals lacking P/Q-type Ca 2ϩ channels (␣ 1A Ϫ/Ϫ), expression of functional non-P/Q-type channels is augmented. These changes included elevation of cerebellar Purkinje cell L-and N-type current density and reduction of cerebellar granule cell R-type current density (Jun et al., 1999) . Hence, expression of Ca 2ϩ channels in a given cell type is not fixed, and up-or down-regulation of other Ca 2ϩ channel subtypes can occur following mutation or ablation of P/Q-type Ca 2ϩ channels.
The tg mutation, despite altering function of the primary subtype of Ca 2ϩ channel normally involved in ACh release, does not cause neuromuscular dysfunction, aside from the obvious gait abnormality. Thus, some other Ca 2ϩ channel subtype(s) assumes control of ACh release at tg neuromuscular junctions. Neuromuscular transmission in tg mice was investigated by Plomp et al. (2000) . Two alterations were observed: 1) rundown of release during high frequency nerve stimulation was increased; and 2) MEPP frequency was increased in a Ca 2ϩ -, Mg 2ϩ -, and K ϩ -dependent manner. Recently, Kaja et al. (2006) demonstrated a slight increase in R-type but not N-type channel contribution in 6-week-old tg mice. However, Ca 2ϩ channel expression is age-dependent, so this may not reflect the mature pattern of Ca 2ϩ channel dependence of ACh release in these mice.
We sought to determine the pharmacological sensitivity of neuromuscular transmission of adult tg mice, specifically, whether loss of functional P/Q-type channels unmasks L-type or another subtype of Ca 2ϩ channels, and what Ca 2ϩ channel subtypes sustain release in tg mice. Immunohistochemical and electrophysiological data were combined to provide an in-depth analysis of the pharmacological types of Ca 2ϩ channels at adult tg motor nerve terminals.
Materials and Methods
Drugs and Chemicals. Nimodipine, S-(Ϫ)-BayK 8644, and HEPES were purchased from Sigma-Aldrich (St. Louis, MO).
-Conotoxin GIIIB and -conotoxin GVIA were purchased from Bachem California (Torrance, CA). -Agatoxin IVA and -conotoxin MVIIC were obtained from Alomone Labs (Jerusalem, Israel). SNX 482 was obtained from Peptides International (Louisville, KY). All chemicals obtained were of the highest purity available. Toxins were prepared as stock solutions in distilled water containing 0.01% bovine serum albumin (w/v), stored frozen at Ϫ20°C, and used within a 2-week period. Before incubation with any of the toxins, 0.01% bovine serum albumin was also added to the buffered saline solution to prevent nonspecific binding of toxin to the chamber, tubing, and glassware. Nimodipine was prepared as a 10 mM stock solution in 100% ethanol and was kept in a dark bottle at 4°C until use. The final working solution with nimodipine contained only 0.1% ethanol (v/v). All experiments using dihydropyridines were done in a darkened room to avoid breakdown of the photolabile compound.
Antibodies against Ca 2ϩ channel ␣ 1 subunits (rabbit anti-Ca v 2.1, P/Q-; anti-Ca v 2.2, N-; anti-Ca v 1.2, L-; and anti-Ca v 2.3, R-type) were obtained from Alomone Labs. Fluorescein (FITC)-conjugated AffiniPure goat anti-rabbit IgG (heavy ϩ light chains) was purchased from Jackson ImmunoResearch Laboratories Inc. (West Grove, PA), Pacific Blue goat anti-mouse IgG (heavy ϩ light chains), and tetramethylrhodamine ␣-bungarotoxin were obtained from Invitrogen (Carlsbad, CA). Anti-mouse IgG1 monoclonal anti-syntaxin clone HPC-1 antibody was obtained from Sigma-Aldrich.
Mice. Breeding pairs of heterozygote C57BL/6J-tg mice were obtained from The Jackson Laboratory (Bar Harbor, ME), and colonies were maintained at Michigan State University Laboratory Animal Resources (East Lansing, MI). Litters were genotyped at weaning 3 weeks after birth (Plomp et al., 2000) . Although the genotype has been well described, because of differences between our results and those published previously (Plomp et al., 2000; Kaja et al., 2006) , we verified the genotype of all of the mice used (data not shown). Homozygote (tg/tg) mice were also identified by their characteristic phenotype consisting of a mild ataxia and occasional attacks of dyskinesia. For all the experiments, we used male mice between 3 and 9 months of age. All experiments were performed in accordance with local university (Michigan State University Laboratory Animal Resources) and national (National Institutes of Health) guidelines and were approved by the University Animal Use and Care Committee.
Electrophysiology. Animals were sacrificed by decapitation following anesthesia with 80% CO 2 and 20% O 2 . The diaphragm muscle with its attached phrenic nerves was then removed and pinned out at resting tension in a Sylgard-coated chamber. For control recordings, the tissue was perfused continuously at a rate of 1 to 5 ml/min with oxygenated (100% O 2 ) physiological saline solution containing 137.5 mM NaCl, 5.0 mM KCl, 1 mM MgCl 2 , 11 mM D-glucose, and 4 mM HEPES and remained at room temperature. pH was adjusted to 7.4 at room temperature (23-25°C) using NaOH. Muscle action potentials were inhibited by pretreating the tissue with 2.5 to 4 M -conotoxin GIIIB for 15 min. This toxin preferentially blocks muscle Na ϩ channels (Cruz et al., 1985; Hong and Chang, 1989) and thus suppresses muscle contractility. This technique allowed recording of EPPs from intact myofibers without the complicating effects of depressing ACh release or blocking postjunctional ACh receptors as would occur in high [Mg 2ϩ ] low [Ca 2ϩ ]-or d-tubocurarine-treated preparations, respectively. Given that during the electrophysiological recordings the preparations were continuously perfused with physiological saline at a rate of 1 to 5 ml/min, they were retreated with 2.5 to 4 M -conotoxin GIIIB for 15 min, after ϳ60 to 90 min, to maintain contractile block.
Involvement of L-type channels in ACh release was determined by testing their sensitivity to the L-type antagonist nimodipine and agonist BayK 8644 (Atchison, 1989) . Paired comparisons were made for each preparation between the drug-free treatment (control) BayK 8644 and following application of BayK 8644 in the presence of nimodipine. Values are expressed as the percentage of quantal content (m) from drug-treated preparations to that of preparation before addition of the drug (control). Likewise, sensitivity to -conotoxin GVIA (-CTx GVIA), SNX 482, -agatoxin IVA (-Aga IVA), and -conotoxin MVIIC (-CTx MVIIC) was used to test for the contribution of N-, R-, P-, and Q-type Ca 2ϩ channels, respectively, to ACh release at tg motor nerve terminals. Cd 2ϩ was used to block all Ca 2ϩ channels nonspecifically. The P/Q-, N-, and R-type antagonists are all essentially irreversible, so only one toxin or drug was applied to any preparation. Two protocols were used to apply toxins. Because of the high concentrations used for the -CTx MVIIC (5 M) study and the initial concentration-response relationship for -Aga IVA (up to 300 nM), for these studies the hemidiaphragm was preincubated in 5 ml of solution containing the corresponding toxin for 1 h before commencing electrophysiological recordings. The solution was constantly aerated with 100% O 2 . For all other experiments (final -Aga IVA responses, -CTx GVIA, SNX 482, nimodipine, BayK 8644, and Cd 2ϩ ), the hemidiaphragm was superfused with the constantly oxygenated (100% O 2 ) solution in which the specific toxin or compound was diluted. -Aga IVA, -CTx GVIA, and SNX 482 were used at 100 nM, 3 M, and 1 M, respectively, and diluted in 10 ml of physiological saline solution. Nimodipine, BayK 8644, and Cd 2ϩ were used in concentrations of 10, 1, and 10 M, respectively, and diluted in 20 ml of physiological saline solution. These concentrations were chosen based on literature determining their effectiveness at murine neuromuscular junctions (cf. Atchison, 1989; Xu et al., 1998; Santafe et al., 2000; Urbano et al., 2001 Urbano et al., , 2003 Flink and Atchison, 2002; Kaja et al., 2006) .
MEPPs and EPPs were recorded using intracellular glass microelectrodes (1.0 mm o.d.; WPI, Sarasota, FL) having a resistance of 5 to 15 M⍀ when filled with 3 M KCl and localized at the end-plate. The phrenic nerve was stimulated at 0.5 Hz with constant current, using a duration of 50 s, by means of a suction electrode attached to a stimulus isolation unit (Grass SIU; Grass Instruments, Quincy, MA) and stimulator (Grass S48). Signals were amplified using a WPI 721 amplifier, digitalized using a PC-type computer and Axoscope 9.0 (Axon Instruments, Foster City, CA) software, and analyzed using MiniAnalysis 6.0 software (Synaptosoft, Decatur, GA).
Control recordings were made from neuromuscular junction preparations isolated from tg/tg, C57BL/6J-tg, and WT mice without any treatment, and following incubation with the individual chemical or toxin for 1 h. For each preparation, recordings from five to 10 endplates were sampled and averaged to determine the mean amplitude of the EPPs and MEPPs before and after addition of any pharmacological treatment, yielding an n value of 1. Each end-plate was sampled for over 5 min, and the last end-plate recorded from, before any treatment, was the first end-plate recorded from after treatment. Amplitudes of MEPPs and EPPs were normalized to a membrane potential of Ϫ75 mV using the formula V c ϭ [V o ϫ (Ϫ75)]/E, where V c is the corrected EPP/MEPP amplitude, V o is the observed EPP/MEPP amplitude, and E is the resting membrane potential. Recordings were rejected if the 10 to 90% rise time was greater than 1.5 ms or if the membrane potential was more depolarized than Ϫ55 mV. The normalized EPPs were corrected for nonlinear summation (McLachlan and Martin, 1981) 
, where V is the uncorrected EPP amplitude, E is the resting membrane potential, and V corr is the corrected EPP amplitude. The m value was calculated using the ratio of the mean amplitude of the corrected EPPs and MEPPs. The effects of nerve terminal depolarization, induced by raising the [K ϩ ] e from 2.5 to 5, 10, and 20 mM, on MEPP frequency were also measured. After a brief period to permit the bath fluid to reach the new [K ϩ ] e (usually 2 min), at least 5 min of MEPPs were recorded at each [K ϩ ] e . When extracellular KCl concentration was raised, equimolar reductions in extracellular NaCl concentration were made.
Separate preparations were used for each unique experiment conducted. For pharmacological studies, each animal served as its own control. Experiments were replicated in at least five animals. The number of animals used in any given experiment is indicated in the respective figure legend or table. Statistical significance between the various treatment groups was analyzed using a one-way analysis of variance (Prism; GraphPad Software Inc., San Diego, CA). Post hoc differences among sample means were analyzed using Tukey's test. For all experiments, statistical significance was set at p Ͻ 0.05. Predrug values for all the animals of a given genotype (WT, C57BL/6 J-tg, tg/tg) were pooled, as the between-animal variance was homogeneous for that group (Prism statistical software; GraphPad Software Inc.).
Immunohistochemistry. Localization of the different Ca 2ϩ channel ␣ 1 subunits at tg and WT mouse motor nerve terminals was compared using fluorescence immunohistochemistry in the extensor digitorum longus (EDL) and triangularis sterni (TS) muscles from animals whose diaphragm was used for pharmacological studies. The EDL is a homogeneous fast twitch type muscle; thus, concerns associated with myofiber-type-dependent differences in structure or function of the neuromuscular junctions were minimized (Gertler and Robbins, 1978; Prakash et al., 1996) . The thinness of the TS muscle allowed us to label neuromuscular junction structures without using cryosectioning techniques that involved prolonged exposure of the preparation to chemicals such as sucrose, yet permitted high-quality images to be obtained. The fiber type of TS muscle is not known. Qualitatively, results obtained from EDL and TS preparation were consistent, showing the same characteristics of distribution among the different ␣ 1 subunits studied at neuromuscular junctions. No attempt was made to quantify potential differences in staining between the two muscle types. Both muscles were pinned out and lightly fixed for 30 min at room temperature in 4% (w/v) paraformaldehyde in 0.1 M phosphate-buffered saline (PBS; composition 137 mM NaCl, 2.7 mM KCl, 1.4 mM NaH 2 PO 4 , and 4.3 mM Na 2 HPO 4 , pH 7.4). The preparation was then washed in PBS for 1 min and treated with 0.1% (w/v) Triton X-100 in PBS for 30 min. EDL tissue was subsequently washed for 15 min and cryoprotected in 20 and 30% (w/v) sucrose each for 24 h. After 48 h, blocks of tissue were embedded in optimal cutting temperature compound (TissueTek, Tokyo, Japan) in a plastic mold on dry ice and stored at Ϫ80°C until use. Longitudinal and cross-sections (30 m thick) were cut on a cryostat (model 5040, Bright Microtome; Bright Instrument Company Ltd., Huntingdon, Cambridge, UK) and mounted onto gelatincoated slides. Because the TS muscle is extremely thin, no cryosectioning was needed. Preparations were double-or triple-labeled using ␣-bungarotoxin as a marker for the postsynaptic ACh receptors (AChR) at the motor end-plate, commercially available monoclonal anti-syntaxin antibody, labeled subsequently with Pacific Blue-tagged secondary antibody as a presynaptic marker and antibodies to the various ␣ 1 subunits of the Ca 2ϩ channels, labeled subsequently with FITC-tagged secondary antibody. Preliminary experiments with WT preparations demonstrated the expected juxtaposition of presynaptic syntaxin with postsynaptic ␣-bungarotoxin (see Fig. 5 ). Thus, these experiments were replicated in only a limited number of preparations because the confocal microscope used for fluorescence quantitation has only two lasers and hence could not support simultaneous collection of data at three wavelengths. The preparations were washed in PBS for 15 min and then incubated at 4°C overnight (ϳ15 h) with the subunit-specific primary antibody and anti-syntaxin antibody. After washing for 1 h with PBS, sections N-and R-Type Ca 2؉ Channels at NMJ in Tottering Mice were incubated for 1 h in fluorescently labeled secondary antibodies, together with rhodamine labeled ␣-bungarotoxin. After several washes, the preparation was mounted with anti-fading fluorescent mounting medium (Vectashield Hard Set; Vector Laboratories, Burlingame, CA). The different color fluorescent signals were collected and integrated using a Leica TCS SL laser scanning confocal microscope (Leica Microsystems, Exton, PA) to determine the spatial localization and distribution of the ␣ 1 subunits relative to the motor end-plate. This microscope allows simultaneous scanning of FITC and tetramethylrhodamine B isothiocyanate, which were excited at 510 and 580 nm, respectively, using an argon/HeNe-G laser. All pictures of the immunofluorescent signals were taken with the same confocal configuration settings (laser intensity, time exposure resolution, and magnification) for each antibody tested. Integrated signals for the different fluorophores were used to generate composite images for determining spatial localization and distribution of fluorescence. In addition, to determine the spatial localization and distribution of the ␣ 1 subunits and syntaxin relative to the motor end-plate, some preparations were also viewed on a Nikon Elipse 2000-U Diaphot-TMD microscope (Nikon, Melville, NY) with a Hamamatsu Orca 285 charge-coupled device camera (Bridgewater, NJ), and images were acquired using MetaImaging software suite (Molecular Devices, Downingtown, PA). This system allows simultaneous composite viewing of sequentially acquired images of FITC-, tetramethylrhodamine B isothiocyanate-, and Pacific Blue-labeled samples. For each TS preparation, three to five surface nerve terminals were selected for quantitation of relative fluorescence levels. Because all of the pictures were taken using the same confocal configuration settings, we used ImageJ software (National Institutes of Health, Bethesda, MD) to calculate and average the fluorescence levels from total pixels corresponding to the green dye in each picture. Averages of the mean values of fluorescence obtained from all the individual nerve terminals sampled were calculated for each specific ␣ 1 subunit studied. Averaged values of fluorescence were compared between the tg and the WT preparations using the values obtained from the WT preparation as control values. Subsequently, the percentage of juxtaposition of the green and the red dye was calculated by dividing the surface of each picture taken into an area of 5 ϫ 5 squares for a total of 25 inner squares. Each inner square in which the green and the red dyes were juxtaposed was taken as 4% juxtaposition. Table 1 compares the amplitudes of EPPs and MEPPs, MEPP frequency, and m for tg/tg and WT mice. When supramaximal electrical stimuli were delivered to the phrenic nerve at 0.5 Hz, the mean amplitude of EPPs and m in tg/tg preparations did not differ significantly (p Ͼ 0.05) from the value obtained in the WT preparations. Likewise, the mean amplitude and frequency of spontaneously occurring MEPPs did not differ between WT and tg/tg preparations. Thus, as suggested by their gross phenotype, neuromuscular transmission in tg/tg mice is not significantly compromised compared with that of WT. An identical set of experiments were performed in heterozygote C57BL/6J-tg preparations, and the results did not differ significantly from those obtained from WT preparations (data not shown).
Results
The P/Q-type Ca 2ϩ channel antagonist -Aga IVA reduced m of EPPs in WT, C57BL/6 J-tg, and tg/tg preparations; however, this reduction was statistically significant in only the C57BL/6 J-tg and WT preparations (p Ͻ 0l.05) (Fig. 1A ).
-Aga IVA (100 nM) reduced m in C57BL/6 J-tg by 60% (Fig.  1A) compared with the ϳ80% reduction in the WT preparation; however, the difference between these two groups was not significant (p Ͼ 0.05). Thus, the heterozygotes (C57BL/6 J-tg) neuromuscular junctions apparently behave as a normal WT. Perhaps the expression of the normal ␣ 1A subunit protein of the P/Q-type Ca 2ϩ channels is not sufficiently reduced in the C57BL/6 J-tg (heterozygotes) to cause alteration in the normal function of the P/Q-type channels. Consequently, there may be no need for compensation of function through other channel phenotypes.
The pharmacological sensitivity of the heterozygotes to other Ca 2ϩ channel antagonists was also examined. These results are shown for all drugs tested in Fig. 1A . For none of these drugs did the C57BL/6J-tg heterozygote response differ significantly from that of WT (p Ͼ 0.05). Thus, for ease of comparison, the following focus is on the comparison of the tg/tg (tg) and WT groups.
L-type Ca 2؉ Channels Do Not Contribute to Release of ACh at tg Neuromuscular Junction. Nimodipine (an L-type antagonist) and BayK 8644 (an L-type agonist) were used to examine whether L-type Ca 2ϩ channels contribute to release of ACh at tg motor nerve terminals. As shown in Fig.  1B , 10 M nimodipine reduced m by 16.3 Ϯ 3.8% of the nimodipine-free treatment value (control) in WT preparations and by only 4.7 Ϯ 2.9% in tg preparations. Neither of these effects was statistically significant (p Ͼ 0.05). Subsequently the preparation was washed with a nimodipine-free solution for 5 min or until EPP amplitude returned to baseline. Subsequent addition of a solution containing BayK 8644 caused a 12.9 Ϯ 3.8% increase in m at WT preparations, but it essentially had no effect at tg preparations. This slight increase in m induced by BayK 8644 in the WT could be prevented by pretreatment with nimodipine (Fig. 1B) .
Neuromuscular Transmission in tg Mice Is Poorly Susceptible to the P/Q-Type Antagonists -Aga IVA and -CTx MVIIC. The effects of P/Q-type antagonist -Aga IVA (100 nM) on EPP amplitude of tg and WT genotypes are shown for representative examples in Figs. 2 and 3 , A through D. Comparing the effects of the two toxins on m revealed that 100 nM -Aga IVA decreased m by ϳ22% in tg and ϳ82.4% in WT preparations (Fig. 2) . Higher concentrations of -Aga IVA (300 nM) had no additional effect in m in tg preparations (Fig. 2) . Likewise, -CTx MVIIC reduced m by 92.4% in WT and 41.3% at tg neuromuscular junctions (Fig. 3A) . Thus, although the two toxins affected each of the two genotypes, 1) a greater effect was seen with the less specific -CTx MVIIC than with -Aga IVA, and 2) the effect of each toxin was greater in the WT than the tg neuromuscular junctions. b All EPPs were evoked at 0.5 HZ and were corrected and adjusted to a standard membrane potential (Ϫ75 mV) to correct for changes in driving force that alter the postjunctional membrane potential.
c Data represent the mean Ϯ S.E.M. of individual preparations that were pooled before any drug or toxin treatment.
d The m value is calculated using the ratio of the mean amplitude of the corrected EPPs and MEPPs.
N-and R-Type Ca
2؉ Channels Contribute to the Majority of Nerve-Evoked ACh Release at tg Neuromuscular Junctions. The contribution of N-and R-type Ca 2ϩ channels to ACh release from tg mice was tested using 3 M -CTx GVIA and 1 M SNX 482, respectively. Figure 4 , A-D, shows representative tracings of the comparative effects of -CTx GVIA and SNX 482 applied alone, or in combination, on EPP amplitude in WT and tg mice. Neither toxin alone nor in combination was effective in WT preparations.
Conversely, both -CTx GVIA and SNX 482 significantly reduced EPP amplitude in the tg preparations (p Ͻ 0.05). The combination of -CTx GVIA and SNX 482 caused a further and significant reduction in EPP amplitude of tg mice. However, even the combined presence of the two toxins did not abolish EPPs in tg mice. Although each toxin caused significant reduction in m compared with pretreatment control for tg preparations, comparing across genotypes, the effects in tg were only statistically significant from WT for SNX 482 and the combined treatment of SNX 482 and -CTx GVIA (Fig.  4B) . Thus, Ca 2ϩ channels sensitive to SNX 482 and -CTx GVIA play a dominant role in neurotransmitter release at the tg motor nerve terminals.
For comparative purposes, 10 M Cd 2ϩ was applied to some preparations to block all Ca 2ϩ channels nonspecifically. This concentration of Cd 2ϩ completely blocked ACh release in tg as well as WT neuromuscular junctions (data not shown). Thus, even though ACh release was not completely blocked by N-or R-type Ca 2ϩ channel antagonists in the tg neuromuscular junction, it was totally sensitive to Cd 2ϩ and in the same concentration range as was WT. K ؉ Induced ACh Release Does Not Differ between tg and WT Mice. Voltage-dependent inactivation of Purkinje cell P/Q-type channels in tg mice is reduced (Wakamori et al., 1998) Channel ␣ 1 Subunits at tg and WT Motor Nerve Terminals. The distribution of ␣ 1A , ␣ 1B , ␣ 1C , and ␣ 1E Ca 2ϩ channel subunits at tg neuromuscular junction, was examined using fluorescence immunohistochemistry in sections of mouse EDL and TS muscles. The relative localization of these sub- Fig. 1 . A, summary of comparative effects of specific Ca 2ϩ channel blockers and agonist on ACh release at C57BL/6J-tg and WT neuromuscular junctions. Preparations were incubated with 100 nM -AgaTx IVA, 3 M -CgTx GVIA, 10 M nimodipine, or 1 M BayK 8644 for 1 h. B, effect of nimodipine and BayK 8644 (BayK) on quantal content of tg/tg and WT mouse neuromuscular junctions. Preparations were incubated for 1 h with 10 M L-type Ca 2ϩ channel blocker nimodipine. Data for effects of BayK 8644 on m of tg/tg mouse hemidiaphragm preparations were collected before (control) and after 1 h of incubation with 1 M BayK 8644 and then following further incubation with 1 M BayK for 45 min in the presence of 10 M nimodipine. In both panels, m was determined for each preparation using the ratio of the average EPP amplitude to the average MEPP amplitude before and after addition of specific drug or toxin. EPPs were elicited at a frequency of 0.5 Hz. Each value represents the mean Ϯ S.E.M. of six WT and seven tg individual preparations. Values are expressed as the percentage of m after treatment with the specific Ca 2ϩ channel agonist or antagonist to that of the pretreatment value. The asterisk ‫)ء(‬ indicates a value significantly different from the control pretreatment value (p Ͻ 0.05). In B, values are expressed as the percentage of m from preparations after the addition of nimodipine to that of the same preparation before nimodipine treatment. 
N-and R-Type Ca 2؉ Channels at NMJ in Tottering Mice
units with respect to the motor end-plates was assessed by comparing staining for subunit-specific antibodies to Ca 2ϩ channels with that of fluorescent ␣-bungarotoxin to label postsynaptic ACh receptors and anti-syntaxin antibody to label the presynaptic membrane.
As shown for the representative images in Fig. 5 , for both WT and tg mice intense staining occurred with antibody against syntaxin (blue) and ␣-bungarotoxin (red). The two stains were highly juxtaposed. Although not evident at the level of resolution of these images (data not shown), antisyntaxin staining frequently exhibited a punctate pattern, as described by Santafe et al. (2005) . Figure 6 demonstrates the punctate distribution of ␣ 1A subunit staining seen in WT preparations. As depicted in the representative images, the ␣ 1A subunit staining was highly juxtaposed with that of the ␣-bungarotoxin labeled end-plate.
The panels on the right of each image depict quantitation of the extent of staining and its superimposition. The distribution and juxtaposition of the two stains is consistent with results described by Day et al. (1997) . However, this pattern of distribution was not observed in the tg preparations. There was little staining of tg preparations with anti-␣ 1A antibody, and what staining occurred did not juxtapose with the clearly demarcated end-plate.
The pattern of immunofluorescent staining for ␣ 1B , ␣ 1C , and ␣ 1E was very different from that of ␣ 1A . In the WT preparations, ␣ 1B and ␣ 1E labeling seemed to be randomly distributed, if it occurred, and it definitely did not juxtapose with ␣-bungarotoxin labeling (data not shown). However, in the tg group, ␣ 1B and ␣ 1E subunit labeling demonstrated expression of both subunits, with some of the staining dis- tributed along the vicinity of the end-plates, and some degree of juxtaposition with the ␣-bungarotoxin label (Fig. 7) . Immunofluorescence distribution of the ␣ 1C subunit seemed to run along the muscle fiber in the WT preparations (data not shown). No ␣ 1C staining was observed at any of the tg motor nerve terminals.
The relative amount of fluorescence for each subunit is compared quantitatively across all preparations for the two genotypes in Fig. 8 . There was a significant increase in the amount of fluorescence corresponding to ␣ 1B (124 Ϯ 6.4%) and especially to the ␣ 1E (2283 Ϯ 10.4%) subunits in tg preparations compared with WT. As expected, the level of staining of ␣ 1A was significantly higher in WT than tg preparations. There was no difference quantitatively between the two genotypes in staining for ␣ 1C , which was negligible in each case.
As a further investigation of the descriptive results obtained in the initial immunohistochemical studies, we quantitated the extent of juxtaposition of ␣ 1 subunit immunofluorescence with that of ␣-bungarotoxin (Fig. 9) . Confocal microscopic imaging demonstrated that 69% of the ␣ 1A labeling was juxtaposed with ␣-bungarotoxin labeling in the WT preparation, but only ϳ19% in the tg preparation. Surprisingly, the percentages of juxtaposition for ␣ 1B and ␣ 1E subunit labeling in tg preparations were only 12.5 and 15% respectively; there was no juxtaposition of either of these subunits with ␣-bungarotoxin in the WT preparations (Fig.  9) . As described above, ␣ 1C subunit seemed to run along the muscle fiber in the WT preparations with a percentage of juxtaposition of 16.66% within the end-plates. No ␣ 1C subunit staining was juxtaposed with ␣-bungarotoxin in the tg group.
Discussion
P/Q-type channels are the normal primary regulators of nerve-evoked ACh release at mammalian neuromuscular junctions (Uchitel et al., 1992; Sugiura et al., 1995) , so one might predict that ␣ 1A subunit mutations in these channels would disrupt murine junctional transmission. However, tg mice exhibit no obvious neuromuscular impairment; hence, P/Q-type channel function is somehow compensated.
This study characterized thoroughly the plasticity of ACh release at motor end-plates in these animals. Effects of the tg mutation on neuromuscular transmission have not been extensively studied. Kaja et al. (2006) suggested a possible compensation of non-Ca v 2.1 channels to evoked ACh release at 6-week-old tg motor nerve terminals. -Aga IVA reduced release by ϳ75% in tg preparations, as opposed to ϳ95% in WT. In addition, ϳ15% sensitivity to SNX 482 and no sensitivity to -CTx GVIA occurred in tg preparations. Our study corroborates some of these findings, but it differs in several ways. Moreover, it extends some findings considerably.
Our results are consistent with the following conclusions: 1) P/Q-type channels contribute poorly to ACh release at adult tg neuromuscular junction, albeit heterozygote neuromuscular transmission is essentially similar to WT. 2) L-type channels do not contribute to ACh release in tg mice. 3) Nand R-type channels assume ACh release control in adult tg motor nerve terminals; however, some release remains insensitive to all toxins but equally sensitive to Cd 2ϩ . 4) At low rate (0.5 Hz) of stimulation, m does not differ between WT and tg. 5) No apparent differences occur in spontaneous release between adult tg and WT preparations.
The differential effect of -Aga IVA on WT and tg heterozygotes was not significant, although it displayed an interesting trend: -Aga IVA-sensitive channels contribute ϳ82% to ACh release at WT, ϳ60% at C57BL/6 J-tg, but only ϳ22% at tg neuromuscular junctions. Thus, fundamentally, the heterozygote neuromuscular junction behaves similarly to WT. Adult tg mice Ca 2ϩ channels showed higher sensitivity to the less specific blocker -CTx MVIIC than to -Aga IVA. Possible explanations for this result include 1) the Q-type splice Immunostaining of WT and tg neuromuscular junctions using an anti-syntaxin antibody and ␣-bungarotoxin. EDL muscles from WT animals were stained with an antibody against two molecular markers of the cellular elements that configure the neuromuscular junction: the acetylcholine receptor (AChR) (red) in muscle cells and syntaxin in nerve terminals (blue). Juxtaposition (pink regions) shows the superimposition of AChR and syntaxin. The topological correspondence of syntaxin with the AChR is almost complete for both genotypes (tg and WT, right and left column, respectively). Scale bar, 15 m.
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variant is more preponderant functionally than is the P-type in tg animals.
2) The -CTx MVIIC binding site is more accessible in the tg mice than is the -Aga IVA site.
3) The selectivity of -CTx MVIIC, especially at concentrations as high as 5 M, is markedly reduced and it also blocks N-type channels (McDonough et al., 2002) . Greater contribution of N-type channels at tg motor axon terminals could be reflected in the greater reduction of m by -CTx MVIIC. This finding is consistent with the subsequent sensitivity of tg neuromuscular transmission to -CTx GVIA. In either case, function of P/Q-type channels is markedly reduced in adult tg mice. In this regard, our results differ significantly from those of Kaja et al. (2006) , who found a higher percentage of sensitivity to -Aga IVA in 6-week-old tg mice. Sensitivity to -CTx MVIIC was not reported. As described below, difference in age of the animals used may contribute to the differences in sensitivity between these studies. A major question we sought to answer was whether L-type channel function was evident at tg neuromuscular junctions. L-type channels are up-regulated in cerebellum (Campbell and Hess, 1999) and basal forebrain (Etheredge et al., 2005) of tg mice; however, we found no contribution of L-type channels to ACh release at adult tg neuromuscular junctions. Up-regulation of L-type channels is a well reported form of plasticity at murine neuromuscular junction. It occurs in adult mice treated chronically with Lambert-Eaton myasthenic syndrome plasma (Smith et al., 1995; Xu et al., 1998; Flink and Atchison, 2002) , reinnervating motor endplates following acute nerve damage (Katz et al., 1996) or botulinum toxin-poisoned nerve terminals (Santafe et al., 2000) . L-type channels are also involved in ACh release in neonatal rats (Sugiura and Ko, 1997) . Although it is possible that L-type channel function at tg neuromuscular junctions is masked by the presence of other channel types such as Ca 2ϩ -dependent K ϩ channels (Flink and Atchison, 2003) , immunolabeling does not reveal ␣ 1C subunit staining at tg neuromuscular junctions. Thus, L-type channel compensation is not generalized either to mutation or to ablation of P/Q-type channels.
ACh release in tg motor nerve terminals is sensitive to the N-and R-type channel antagonists -CTx GVIA and SNX 482, respectively. The immunolabeling demonstrates in- Fig. 6 . Confocal images and three-dimensional rendering of pixel density distribution of ␣ 1A subunits at representative WT and tg motor nerve terminals. TS muscle from WT and tg animals were stained with ␣-bungarotoxin (red) and an antibody against the ␣ 1A subunit of Ca 2ϩ channels (green). Juxtaposition (yellow regions) shows the superimposition of AChR and ␣ 1A subunits. Note that in WT preparations (left column), ␣ 1A subunit staining exhibits a punctate distribution over the surface of the ␣-bungarotoxin-labeled end-plate, with a high degree of juxtaposition. This pattern of distribution was not observed in the tg preparations (right column). Scale bar, 10.8 m for the WT and 10.9 m for tg images.
creased fluorescence for ␣ 1B , but especially for ␣ 1E in tg mice. Pharmacological studies also demonstrated a greater contribution of R-as opposed to of N-type channels to release. Hence, both types of data suggest a relocation-recruitment, or up-regulation of ␣ 1B and ␣ 1E subunits at tg neuromuscular junctions. Presumably, this occurs to compensate for the loss of function of ␣ 1A subunits. These channel subtypes apparently act synergistically in tg mice. This response is identical to that seen at neonatal mouse neuromuscular junctions of P/Q-type nullzygotes (Urbano et al., 2003) . In central nervous system nerve terminals in tg mice, N-type channels apparently are solely responsible for (Qian and Noebels, 2000) or predominate in controlling glutamate release (Leenders et al., 2002; Zhou et al., 2003) . Neither of these studies tested responsiveness to SNX 482, and in neither case did -CTx GVIA abolish release, so it is possible that an R-type component contributed to glutamate release in their experiments. We observed no significant changes at WT neuromuscular junction with either of these pharmacological treatments, and heterozygotes did not express sensitivity to -CTx GVIA (SNX 482 was not tested). Consequently, N-and R-type channels primarily mediate ACh release at tg neuromuscular junctions. Why multiple subtypes of Ca 2ϩ channels are necessary to replace a process that is normally almost exclusively dependent on a single subtype of Ca 2ϩ channel is unclear.
The finding of contributions of both N-and R-type channels to ACh release differs from those of Kaja et al. (2006) . They saw no effect of -CTx GVIA and only a modest reduction of m (15%) with SNX 482l. The percentage reduction of ACh release caused by -CTx GVIA in our study was virtually identical to that in cerebellar synaptosomes (Zhou et al., 2003) . The Kaja et al. (2006) study did not include immunohistochemical data, so it is unknown whether N-type channels were present at tg motor nerve endings, but did not contribute to ACh release. Differences between our two studies are most likely due to age-related factors. Several studies have demonstrated developmental changes in Ca 2ϩ channel expression (Gray et al., 1992; Rosato Siri and Uchitel, 1999) . Full expression of ␣ 1B and ␣ 1E subunits may not occur until later than 6 weeks postnatal in tg mice. Thus, at the comparatively young age of mice in which Kaja et al. (2006) Fig. 7 . Confocal images and 3D rendering of pixel density distribution of ␣ 1B and ␣ 1E subunits at representative tg motor nerve terminals. TS muscle from tg mice were stained with ␣-bungarotoxin (red) and an antibody against the ␣ 1B (left column) or ␣ 1E (right column) subunits of Ca 2ϩ channels (green). Juxtaposition (yellow mark) shows the superimposition of AChR and ␣ 1B or ␣ 1E subunits. These confocal images and 3D renderings of pixel density distribution of ␣ 1B and ␣ 1E subunits show what seems to be an increase in the pattern of expression of ␣ 1B and ␣ 1E subunits labeling with a distribution along the vicinity of the end-plates and with some degree of juxtaposition with the ␣-bungarotoxin label. Scale bar, 26 m for the ␣ 1B and 20.3 m for ␣ 1E images.
N-and R-Type Ca
2؉ Channels at NMJ in Tottering Mice examined neuromuscular function, there may have been a greater dependence on P/Q-type (hence, the larger percentage of sensitivity of their animals to -Aga IVA), and a lesser contribution of N-or R-type channels (slight sensitivity to SNX 482 and no sensitivity to -CTx GVIA) than in 3-to 9-month-old animals we used.
Although our results support up-regulation of R-type Ca 2ϩ channels as a compensatory mechanism for the functional loss of P/Q-type channels at tg neuromuscular junctions, reports suggest that SNX 482 may not only block R-type but also P/Q- (Arroyo et al., 2003) and N-type channels (Neelands et al., 2000) . However, our immunohistochemical studies correlate with the pharmacological studies in that ␣ 1B and ␣ 1E staining is clearly evident at tg neuromuscular junctions, lending credence to the notion that R-type channels are present at tg terminals and play an important role in ACh release. Similar findings are described previously (Pagani et al., 2004) at ␣ 1A knockout neuromuscular junctions. Neither our pharmacological nor immunohistochemical results suggested presence of R-type channels at WT neuromuscular junction. Considerable phenotypic difference exists between the ␣ 1A knockout and tg mouse, both of which have impaired P/Q-type channel function, and show compensatory increases in N-and R-type channels. In ␣ 1A knockout mice, deletion of P/Q-type channels is lethal (Fletcher et al., 2001) , despite compensatory plasticity changes in Ca 2ϩ channel phenotype (Jun et al., 1999) . Conversely, in tg mice, although the single amino acid substitution results in largely dysfunctional P/Q-type channels, some sensitivity to -Aga IVA remains even into adulthood. Nonetheless, other non-P/Q-type Ca 2ϩ channels are recruited to control ACh release and this release is sufficient to support normal neuromuscular function to adulthood. Perhaps the presence of a small fraction of P/Q-type channels in the tg mice suffices to permit function until sufficient recruitment of non-P/Q-type channels occurs. If this is the case, the fact that in tg mice ␣ 1A protein is still expressed, albeit impaired functionally, may allow normal organization of the release apparatus and hence survival.
Despite the importance of SNX 482-sensitive ACh release to tg neuromuscular transmission, an aspect of the immunohistochemical data is puzzling. Although staining for ␣ 1E was greater than that of ␣ 1B in tg mice (Fig. 8) , the percentage of juxtaposition of ␣ 1E staining with ␣-bungarotoxin was low, in fact, no higher than that of ␣ 1A or ␣ 1B (Fig. 9) . This implies that the R-type channels may not be closely localized to active zones. Urbano et al. (2003) suggest that there is a "preferred order" of insertion of highvoltage-activated Ca 2ϩ channels into nerve terminal membrane in the active zones. R-type channels are suggested to be "preferred" over N-type. Certainly our data indicate more control by R-than N-type channels of release in tg mice, but one would have expected a greater level of juxtaposition of the ␣ 1E staining with the ␣-bungarotoxin than was observed. More extensive analyses of this will be needed to resolve this conundrum.
Previous reports (Plomp et al., 2000; Kaja et al., 2006 ) indicated that resting MEPP frequency and response to depolarization with 10 mM KCl was increased in tg mice. However, we found no increase in resting MEPP frequency in either tg or C57BL6/tg mice, and the response to sustained depolarizations at [KCl] up to 20 mM was equivalent in tg and WT mice. The basis for this difference in result may be methodological. Although no details of the MEPP recordings were provided in Plomp et al. (2000) , Kaja et al. (2006) report measuring at least 30 MEPPs at each neuromuscular junction. At the reported frequencies in their article (2.04 MEPPs/s in tg; 0.96 MEPPs/s in WT), this implies recordings of as little as 15 to 30 s. We sampled over a much longer interval. At a frequency of 1 Hz, for 5 min (our minimal sampling duration), we would sample ϳ300 MEPPs. Short Fig. 8 . Relative pixel count of fluorescence corresponding to ␣ 1 subunits at WT and tg neuromuscular junctions. Average fluorescence levels after staining TS muscle preparations with an antibody against the ␣ 1A , ␣ 1B , ␣ 1C , or ␣ 1E subunits of Ca 2ϩ channels. For each preparation, three to five surface nerve terminals were selected by eye for quantitation of fluorescence intensity. The average of relative pixel count for each ␣ 1 subunit in tg terminals was normalized to the average of pixel count in WT mice. Each value represents the mean Ϯ S.E.M. of three tg and WT individual preparations. Fig. 9 . Percentage of juxtaposition of ␣ 1 Ca 2ϩ subunits with AChR at WT and tg neuromuscular junctions. Values are taken from the data for all neuromuscular junctions sampled as depicted in Fig. 8 . Percentage of juxtaposition of ␣-bungarotoxin (red) and an antibody against the various ␣ 1 subunits of Ca 2ϩ channels (green) was calculated by dividing the surface or each picture taken into a perfect square of 5 by 5 squares for a total of 25 inner squares. Each inner square in which the green and the red dyes were juxtaposed was taken as 4% of juxtaposition. For each preparation, three to five surface nerve terminals were selected by eye for quantitation of juxtaposition. Each value represents the mean Ϯ S.E.M. of three tg and WT individual preparations. Where no histogram is shown, no measurable ␣ 1 subunit staining juxtaposed with that of ␣-bungarotoxin.
time intervals could easily magnify apparent differences in MEPP frequency, which would "average out" over longer intervals. This is especially true if "clusters" of MEPPs occurred (Fatt and Katz, 1952; Kriebel and Stolper, 1975; Vautrin and Kriebel, 1991) for whatever reason during a brief recording episode. Alternatively, perhaps younger mice exhibit a greater difference in MEPP frequency between the two genotypes. This would need to be examined more rigorously, however, to substantiate.
In conclusion, the type of channel that can control ACh release at mammalian neuromuscular junction is not fixed. R-and N-type Ca 2ϩ channels contribute to ACh release at mammalian neuromuscular junctions under specific conditions such as following P/Q-type channel ablation in ␣ 1A knockout animals (Jun et al., 1999; Urbano et al., 2003) or P/Q-type channel mutation. Therefore, recruitment of alternate subtypes of Ca 2ϩ channels to overcome deficiency in the normal complement seems to represent a commonly occurring method of neuronal plasticity. However, the identity of the compensatory type of Ca 2ϩ channel(s) is not constant. Furthermore, even in the same genotype, plasticity varies from central nervous system to peripheral synapses. In each case, the apparent goal is to preserve synaptic function. However, different ␣ 1 subunits have distinct biophysical as well as pharmacological properties, so substitution of one phenotype of Ca 2ϩ channel with another is unlikely to be "seamless". The "rules" by which this up-regulation occurs are not yet clear, but they could play an important role in determining compensation at synapses in which Ca 2ϩ channel function is altered.
